Mesenchymal stem/stromal cells (MSCs) are stromal-derived non-hematopoietic progenitor ... adipose tissue, amniotic fluid, placenta, dental pulp and skin. The discovery of the immunosuppressing action ...
Mesenchymal stem cells (MSCs), or mesenchymal stromal cells ... have utilized the experimental autoimmune encephalomyelitis (EAE) murine model of MS to show that human placental MSC (hP-MSC)-derived ...
Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...
Extraembryonic trophoblast lineages constitute the placenta, and are essential for individual development. In human early embryo development, these cells can be generated from totipotent blastomeres.
The novel drug CT-179 ... How Healthy Stem Cells Turn Into Oral Cancer Feb. 4, 2025 — Researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into ...
More information: Barbara Klein et al, Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats, Molecular Therapy (2024). DOI: 10.1016/j.ymthe.
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...
The placental progenitor stem cell is the cytotrophoblast cell. These cells are responsible for the cellular growth of the placenta, and they have the ability to proliferate and differentiate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback